Literature DB >> 21786192

Ca2+ signalling in cardiovascular disease: the role of the plasma membrane calcium pumps.

Elizabeth J Cartwright1, Delvac Oceandy, Clare Austin, Ludwig Neyses.   

Abstract

The plasma membrane calcium ATPases (PMCA) are a family of genes which extrude Ca(2+) from the cell and are involved in the maintenance of intracellular free calcium levels and/or with Ca(2+) signalling, depending on the cell type. In the cardiovascular system, Ca(2+) is not only essential for contraction and relaxation but also has a vital role as a second messenger in signal transduction pathways. A complex array of mechanisms regulate intracellular free calcium levels in the heart and vasculature and a failure in these systems to maintain normal Ca(2+) homeostasis has been linked to both heart failure and hypertension. This article focuses on the functions of PMCA, in particular isoform 4 (PMCA4), in the heart and vasculature and the reported links between PMCAs and contractile function, cardiac hypertrophy, cardiac rhythm and sudden cardiac death, and blood pressure control and hypertension. It is becoming clear that this family of calcium extrusion pumps have essential roles in both cardiovascular health and disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786192     DOI: 10.1007/s11427-011-4199-1

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  15 in total

1.  Gelsolin (GSN) induces cardiomyocyte hypertrophy and BNP expression via p38 signaling and GATA-4 transcriptional factor activation.

Authors:  Wei-Syun Hu; Tsung-Jung Ho; Peiying Pai; Li-Chin Chung; Chia-Hua Kuo; Sheng-Huang Chang; Fuu-Jen Tsai; Chang-Hai Tsai; Yu-Chi Jie; Ying-Ming Liou; Chih-Yang Huang
Journal:  Mol Cell Biochem       Date:  2014-02-07       Impact factor: 3.396

Review 2.  Ca2+-dependent transcriptional control of Ca2+ homeostasis.

Authors:  Jose R Naranjo; Britt Mellström
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

3.  Identification of critical molecular pathways involved in exosome-mediated improvement of cardiac function in a mouse model of muscular dystrophy.

Authors:  Xuan Su; Yan Shen; Yue Jin; Neal L Weintraub; Yao-Liang Tang
Journal:  Acta Pharmacol Sin       Date:  2020-06-29       Impact factor: 6.150

4.  RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment.

Authors:  A I Lynch; M R Irvin; E Boerwinkle; B R Davis; L K Vaughan; C E Ford; B Aissani; J H Eckfeldt; D K Arnett; S Shrestha
Journal:  Pharmacogenomics J       Date:  2012-06-05       Impact factor: 3.550

5.  Target network differences between western drugs and Chinese herbal ingredients in treating cardiovascular disease.

Authors:  Peng Fu; Linlin Yang; Yi Sun; Li Ye; Zhiwei Cao; Kailin Tang
Journal:  BMC Bioinformatics       Date:  2014-03-19       Impact factor: 3.169

6.  Association of the histone-lysine N-methyltransferase MLL5 gene with coronary artery disease in Chinese Han people.

Authors:  Qinghua Yuan; Xiang Xie; Zhenyan Fu; Xiang Ma; Yining Yang; Ding Huang; Fen Liu; Chuanfang Dai; Yitong Ma
Journal:  Meta Gene       Date:  2014-07-31

7.  Transient receptor potential canonical type 3 channels control the vascular contractility of mouse mesenteric arteries.

Authors:  Soo-In Yeon; Joo Young Kim; Dong-Soo Yeon; Joel Abramowitz; Lutz Birnbaumer; Shmuel Muallem; Young-Ho Lee
Journal:  PLoS One       Date:  2014-10-13       Impact factor: 3.240

8.  Calcium Extrusion Pump PMCA4: A New Player in Renal Calcium Handling?

Authors:  Ellen P M van Loon; Robert Little; Sukhpal Prehar; René J M Bindels; Elizabeth J Cartwright; Joost G J Hoenderop
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

9.  Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III.

Authors:  Mieke Van Hemelrijck; Karl Michaelsson; Jakob Linseisen; Sabine Rohrmann
Journal:  PLoS One       Date:  2013-04-10       Impact factor: 3.240

10.  Acute inhibition of PMCA4, but not global ablation, reduces blood pressure and arterial contractility via a nNOS-dependent mechanism.

Authors:  Sophronia Lewis; Robert Little; Florence Baudoin; Sukhpal Prehar; Ludwig Neyses; Elizabeth J Cartwright; Clare Austin
Journal:  J Cell Mol Med       Date:  2017-11-30       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.